Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03337243 · ClinicalTrials.gov registry record · NA
Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis
A NA study, sponsored by Sport and Spine Rehab Clinical Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03337243 is a NA study that has completed, run by Sport and Spine Rehab Clinical Research Foundation. The registered enrollment target is 60 participants.
The verdict
NCT03337243, a NA study, has completed, sponsored by Sport and Spine Rehab Clinical Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the pain, functioning and pain medication consumption of knee osteoarthritis (OA) patients who have allogenic cytokines derived from human amniotic membranes (HAM) and allogenic mesenchymal stem cells derived from human umbilical cord Wharton's Jelly (HUMCWJ) implanted into the affected knee with knee OA patients who self-select to be in a non-intervention control group.
Interventions
- PROCEDURE HAM and HUMCWJ Injections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2019-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03337243
The ClinicalTrials.gov registry entry for NCT03337243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sport and Spine Rehab Clinical Research Foundation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HAM and HUMCWJ Injections is the first listed.
NCT03337243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03337243 about?
NCT03337243 is a clinical study titled "Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis". The purpose of this study is to compare the pain, functioning and pain medication consumption of knee osteoarthritis (OA) patients who have allogenic cytokines derived from human amniotic membranes (HAM) and allogenic mesenchymal stem cells derived from human umbilical cord Wharton's Jelly (HUMCWJ) ...
What is the current status of trial NCT03337243?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-11-09. Estimated completion is 2019-04-26.
What interventions are being tested in trial NCT03337243?
The interventions under investigation include: HAM and HUMCWJ Injections (PROCEDURE).
Who is sponsoring clinical trial NCT03337243?
This trial is sponsored by Sport and Spine Rehab Clinical Research Foundation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.